Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved.

Why these top 4 ASX travel and airline stocks surged on Tuesday

With BioNTech and Pfizer announcing a potentially game-changing covid-19 vaccine overnight, ASX-listed travel and airline stocks surged when trade resumed on Tuesday.

Why these top 4 ASX travel and airline stocks surged on Tuesday Source: Bloomberg

The beginning of a sharp rotation?

Airline and travel stocks have been some of the worst hit as a result of the coronavirus pandemic.

Indeed, just a month ago, a bet on the recovery of airline stocks might have just been the ultimate contrarian play: planes have been grounded, cash flows have been squeezed and the outlook for the industry was marred by deep uncertainty.

That uncertainty appears to have diminished significantly almost in a flash, with biotech giants BioNTech (+13.91%) and Pfizer (+7.69%) overnight announcing that its coronavirus vaccine had proved to be more than 90% effective during its recent phase 3 study – conducted with more than 40,000 participants.

‘Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,’ said Pfizer’s CEO Dr Albert Bourla.

Qantas, Webjet and Sydney Airport share prices surge on vaccine assumptions

The promise of an effective vaccine saw the Australian market split down the middle, as many of the stocks hyped up during the pandemic were sold off. On the one hand, investors bid up beaten down and out-of-favour stocks such as airline and travel stocks to new multi-month highs. Looking at the price action from the open:

Ultimately, while the prospect of a vaccine unlocking international travel sooner than previously expected would be a distinct positive for ASX-listed travel and airline stocks, it should be noted that BioNTech and Pfizer’s vaccine, though promising, still must be approved by the FDA. Both companies are currently collating the relevant efficacy as well as safety and manufacturing data to that end.

Despite that hurdle, it was noted that some 50 million vaccine doses could be produced by the close of 2020 and as much as 1.3 billion doses in 2021.

E-commerce stocks plunge

Of course, while airline and travel stocks were bid higher on the prospect of sooner-than-expected international air travel; ASX-listed ecommerce stocks, that proved so popular amongst investors during the height of the pandemic, were abandoned by the market.

By 11:10AM, art-focused online marketplace Redbubble had seen its share price fall 17.81% to $4.06 per share; online furniture dealer Temple & Webster had crashed a staggering 19.92% to $10.01 per share, and meals delivery company Marley Spoon was down 20.46%, to 2.06 per share.

How to trade ASX travel stocks

You can use CFDs to trade some of the airline and travel stocks we have discussed today – LONG or SHORT – through IG’s world-class trading platform now. For example, to buy (long) or sell (short) Sydney Airport using CFDs, follow these easy steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘Sydney Airport’ or ‘SYD’ in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access
Learn more

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off
Log in now

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform
Log in now

See opportunity on a stock?

Don’t miss your chance. Log in to take your position.

Take advantage

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.